Summary
Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment of sickle cell disease (SCD) is in Phase II clinical trial statge. Its GBT440 is a hemoglobin modifier which targets the mechanism of red blood cell sickling for the treatment of SCD. GBT’s pipeline also includes an oral kallikrein inhibitor to prevent hereditary angioedema (HAE) attacks. The company also develops therapies which are in preclinical and preliminary clinical stage for the treatment of for acute and chronic hypoxemic pulmonary disorders such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). It offers chemical and biological mechanisms of blood-based disorders. GBT is headquartered in South San Francisco, California, the US.
Global Blood Therapeutics Inc (GBT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Global Blood Therapeutics Raises USD48 Million in Series B Financing 10
Global Blood Therapeutics Raises US$50 Million In Series A Financing 12
Partnerships 13
HitGen Enters into Research Agreement with Global Blood Therapeutics 13
Array BioPharma Enters Into Drug Discovery Agreement With Global Blood Therapeutics 14
Licensing Agreements 15
Global Blood Therapeutics Enters Licensing Agreement with Regents of the University of California 15
Equity Offering 16
Global Blood Therapeutics Raises USD143.8 Million in Public Offering of Shares 16
Global Blood Therapeutics Raises USD120 Million in Public Offering of Shares 18
Global Blood Therapeutics Raises USD138 Million in IPO of Shares 20
Global Blood Therapeutics Raises Funds through Private Placement of Shares 22
Acquisition 23
Novo Nordisk May Acquire Global Blood Therapeutics 23
Global Blood Therapeutics Inc - Key Competitors 24
Global Blood Therapeutics Inc - Key Employees 25
Global Blood Therapeutics Inc - Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 07, 2017: Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial Results 27
May 01, 2017: Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2017 Financial Results 29
Mar 13, 2017: Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results 30
Nov 09, 2016: Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2016 Financial Results 32
Aug 10, 2016: Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2016 Financial Results 34
May 12, 2016: Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2016 Financial Results 36
Mar 29, 2016: Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results 37
Corporate Communications 39
Apr 04, 2016: Global Blood Therapeutics Announces Appointment of Jeffrey Farrow as CFO 39
Feb 08, 2016: Global Blood Therapeutics Announces Changes to Board of Directors 40
Jan 04, 2016: Global Blood Therapeutics Appoints Scott Morrison to Board of Directors 41
Product News 42
05/19/2016: Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Associations 21st Congress 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Global Blood Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Global Blood Therapeutics Raises USD48 Million in Series B Financing 11
Global Blood Therapeutics Raises US$50 Million In Series A Financing 13
HitGen Enters into Research Agreement with Global Blood Therapeutics 14
Array BioPharma Enters Into Drug Discovery Agreement With Global Blood Therapeutics 15
Global Blood Therapeutics Enters Licensing Agreement with Regents of the University of California 16
Global Blood Therapeutics Raises USD143.8 Million in Public Offering of Shares 17
Global Blood Therapeutics Raises USD120 Million in Public Offering of Shares 19
Global Blood Therapeutics Raises USD138 Million in IPO of Shares 21
Global Blood Therapeutics Raises Funds through Private Placement of Shares 23
Novo Nordisk May Acquire Global Blood Therapeutics 24
Global Blood Therapeutics Inc, Key Competitors 25
Global Blood Therapeutics Inc, Key Employees 26
List of Figures
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Global Blood Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
